Funding for this research was provided by:
National Center for Advancing Translational Sciences (TR003103-01, TR003103-01, TR003103-01)
American Heart Association (19CSL0134580004, 19CSL0134580004, 19CSL0134580004, 19CSL0134580004)
Pauley Heart Center (Pilot Grant, Pilot Grant)
Received: 1 September 2021
Accepted: 23 October 2021
First Online: 8 November 2021
: Institutional review board approval was obtained from VCU and University of Michigan prior to the start of the trial, with University of Michigan relying on the VCU IRB. IRB HM20015843; Initial approval date: 8/5/2019.
: Not applicable.
: Dr. Abbate (AA) has served as consultant to Swedish Orphan Biovitrum in the past. Dr. Van Tassell (BVT) has served as consultant to Swedish Orphan Biovitrum in the past. No other authors have relevant disclosures.